Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiac arrest and hypertrophic cardiomyopathy. Role of the implantable defibrillator.

× No keyword cloud information.

17 in total

1. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.

Authors: P Camici; G Chiriatti; R Lorenzoni; R C Bellina; R Gistri; G Italiani; O Parodi; P A Salvadori; N Nista; L Papi
Journal: J Am Coll Cardiol Date: 1991-03-15 Impact factor: 24.094

2. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test.

Authors: D M Gilligan; P Nihoyannopoulos; W L Chan; C M Oakley
Journal: Circulation Date: 1992-06 Impact factor: 29.690

Review 3. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

Authors: B J Maron; R O Bonow; R O Cannon; M B Leon; S E Epstein
Journal: N Engl J Med Date: 1987-03-26 Impact factor: 91.245

4. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.

Authors: V Dilsizian; R O Bonow; S E Epstein; L Fananapazir
Journal: J Am Coll Cardiol Date: 1993-09 Impact factor: 24.094

5. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.

Authors: A C Powell; T Fuchs; D M Finkelstein; H Garan; D S Cannom; B A McGovern; E Kelly; G J Vlahakes; D F Torchiana; J N Ruskin
Journal: Circulation Date: 1993-09 Impact factor: 29.690

6. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery.

Authors: K J Anand; P R Hickey
Journal: N Engl J Med Date: 1992-01-02 Impact factor: 91.245

7. "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death.

Authors: B J Maron; L C Lipson; W C Roberts; D D Savage; S E Epstein
Journal: Am J Cardiol Date: 1978-06 Impact factor: 2.778

8. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Authors: R Anan; G Greve; L Thierfelder; H Watkins; W J McKenna; S Solomon; C Vecchio; H Shono; S Nakao; H Tanaka
Journal: J Clin Invest Date: 1994-01 Impact factor: 14.808

9. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Authors: L Fananapazir; A C Chang; S E Epstein; D McAreavey
Journal: Circulation Date: 1992-09 Impact factor: 29.690

10. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest.

Authors: L Fananapazir; S E Epstein
Journal: Am J Cardiol Date: 1991-02-01 Impact factor: 2.778